The use of lysozyme determination in myeloma
Liso, V.; Troccoli, G.; Grande, M.
Haematologica 58(11): 798-799
1973
ISSN/ISBN: 0390-6078 PMID: 4203592 Document Number: 62300
Document emailed within 1 workday
Related Documents
Rudders, R.A.; Bloch, K.J. 1971: Myeloma renal disease: evaluation of the role of muramidase (lysozyme) American Journal of the Medical Sciences 262(2): 79-85Melekhin, V.D.; Rybina, T.V. 1981: Determination of the concentration and discharge of lysozyme in the saliva Laboratornoe Delo 12: 736-738
Blinova, M.I.; Kagramanova, K.A.; Kulikova, K.S.; Ermol'eva, Z.V. 1973: Determination of lysozyme in the tissues and organs of white mice Antibiotiki 18(6): 550-551
Gyöngyössi, G.; Kelentey, B.; Kelenhegyi, M. 1979: Serum and urine lysozyme determination in subrenal uremia Orvosi Hetilap 120(6): 325-328
Barretto, O.C.; Jamra, M.; Nonoyama, K. 1976: Improved turbidity technic for the determination of lysozyme activity Revista do Hospital das Clinicas 31(6): 446-448
Janke, W.; Langmaack, H.; Tiburtius, H. 1973: Determination of the activity of lysozyme of tears with a method clinically applicable Klinische Monatsblatter für Augenheilkunde 163(3): 366-369
Zabirov, I.S.; Revina, E.N.; Kleshnia, V.M. 1975: Method of determination of lysozyme activity in the sputum and its fluctuations in pneumonia Laboratornoe Delo 7: 424-425
Titov, L.P. 1978: Method of kinetic determination of lysozyme activity in biological fluids of the body Laboratornoe Delo 10: 606-609
Helal, R.; Melzig, M.F. 2008: Determination of lysozyme activity by a fluorescence technique in comparison with the classical turbidity assay Die Pharmazie 63(6): 415-419
Perunova, N.B.; Andriushchenko, S.V.; Bukharin, O.V. 2012: Genetic determinants of secreted lysozyme inhibitors and enterobacteria anti-lysozyme phenotype Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 8-12
Hashimoto, S.; Kira, A.; Imamura, M.; Masuda, T. 1982: Lysozyme dimer formation on lysozyme oxidation with Br2 radical as studied by fluorescence evolution International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 41(3): 303-314
Babaian, S.S.; Pokidova, N.V.; Ermol'eva, Z.V. 1974: The effect of human lysozyme and egg lysozyme on tissue cultures Antibiotiki 19(1): 83-86
Snigurowicz, J.; Powiertowska-Rezmer, M.; Rostkowska, J. 1979: Determination of subclasses of myeloma proteins M-IgG by enzymatic hydrolysis Archivum Immunologiae et Therapiae Experimentalis 27(5): 669-679
Tor, J.; Pahissa, A.; Vilaseca, J. 1981: Asymptomatic hyponatremia in multiple myeloma. Value of anion gap determination Revista Clinica Espanola 162(1-2): 65-66
Kraj, M.; Maj, S.; Pogłód, R.; Rostkowska, J. 1989: Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma Acta Haematologica Polonica 20(2): 140-151
Okano, K.; Yamamoto, K.; Ueda, J.; Fujii, Y.; Yonehara, Y.; Araki, M. 1994: The interrelation of serum lysozyme level and cytoplasmic lysozyme level Rinsho Byori. Japanese Journal of Clinical Pathology 42(3): 278-282
Deng, H.S. 1984: Determination and analysis of lysozyme and IgA in dental plaque and saliva and IgG in saliva of patients with dental caries and gingivitis Zhonghua Yi Xue Za Zhi 64(10): 598-600
Golenkov, A.K.; Mitina, T.A.; Kogarko, I.N.; Liubimova, N.V.; Klinushkina, E.F.; Baryshnikov, A.I. 2009: Pharmacodynamic characteristics of velcade efficacy in resistant and recurrent multiple myeloma: determination of free light chains of blood serum immunoglobulins Terapevticheskii Arkhiv 81(7): 37-41
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Leinonen, P.; Somer, T. 1988: Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins Duodecim; Laaketieteellinen Aikakauskirja 104(18): 1466-1470